Page last updated: 2024-09-04

moxifloxacin and Infectious Endophthalmitis

moxifloxacin has been researched along with Infectious Endophthalmitis in 131 studies

Research

Studies (131)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	30 (22.90)	29.6817
2010's	71 (54.20)	24.3611
2020's	30 (22.90)	2.80

Authors

Authors	Studies
Das, T; Dave, VP; Joseph, J; Reddy, JC; Sharma, S; Singh, VM	1
Corrales, MI; Galvis, V; Garcia, D; Parra, MM; Rangel, CM; Sánchez-Ávila, R; Tello, A; Varón, CL; Villareal, E; Villarreal, D	1
Horita, N; Kaneko, T; Kato, A; Masuhara, N; Mizuki, N; Namkoong, H; Nomura, E; Takeuchi, M	1
Arshinoff, SA; Shi, RB	2
Jeeva, IK; Masud, S; Siddiqui, MAR	1
Cherney, EF; Daniels, AB; Kim, SJ; Law, JC; Patel, SN; Taubenslag, KJ	1
Chang, DF; Mah, FS; Mamalis, N; Miller, KM; Myers, WG; Shorstein, NH	1
Garat, M; Lecumberri Lopez, M; Martín-Baranera, M; Moser, CL	1
Bena, J; Gans, R; Goshe, J; Li, A; Shao, J	1
Mamalis, N	1
Arshinoff, SA; Felfeli, T; Modabber, M	1
Alves, P; Bozukova, D; Coimbra, P; Colaço, R; Filipe, HP; Galante, R; Gil, MH; Guiomar, AJ; Mamalis, N; Masson, M; Mata, J; Oliveira, AS; Pimenta, A; Saramago, B; Serro, AP; Topete, A; Vieira, AP; Werner, L	1
Benetz, BA; Chang, DF; Gardner, S; Lass, JH; Menegay, HJ; OʼBrien, RC; Prajna, NV; Rajendrababu, S; Rhee, DJ; Shekar, M; Szczotka-Flynn, LB	1
Arshinoff, SA; Modabber, M	4
Gardner, S; Shorstein, NH	1
Ali, A; Imtirat, A; Khalili, S; Mireskandari, K; Tehrani, N; Williams, S	1
Das, T; Khanna, RC; Rathi, VM; Sharma, S	1
Agarwal, D; Kumar, A	1
Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS	1
De-La-Torre, A; Gutiérrez, NM; Muñoz-Ortiz, J; Peñaranda-Henao, M; Reyes-Guanes, J	1
Hinkle, DM	1
Alves, M; Cardoso da Silva, I; Cavalcanti Lira, RP; Ferreira, BG; Leite Arieta, CE; Mélega, MV; Nascimento, MA	1
Kohli, GM; Malhotra, PP; Sen, A; Shenoy, P; Shetty, S; Tripathi, S	1
de-la-Torre, A; Muñoz-Ortiz, J; Reyes-Guanes, J	1
Ho, AC; Patel, SN; Peck, TJ	1
Agarwal, A; Nagpal, M	1
Bhojwani, D	1
Arshinoff, SA; Hu, A; Lukewich, MK; Modabber, M	1
Carolan, JA; Herrinton, L; Liu, L; Shorstein, NH	1
Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC	1
Agrawal, R; Bhatia, P; Goh, EJH; Kashikar, R; Kohli, GM; Naman, V; Sachdeva, M; Sen, A; Sen, P; Shenoy, P; Sood, D	1
Jethani, JN; Mathew, BC; Patel, A; Porwal, AC	1
Matsuura, K	2
Bardeci, LAZ; Grzybowski, A	1
Libre, PE; Mathews, S	1
Grzybowski, A; Turczynowska, M	1
Alves, P; Bozukova, D; Coimbra, P; Correia, IJ; Correia, TR; Gil, MH; Guiomar, AJ; Mata, JLGC; Pimenta, AFR; Serro, AP; Silva, D; Vieira, AP	1
Tripathy, K	1
Boianovsky, C; Godoy, RB; Lake, J; Saraiva, TJ; Vieira, IV	1
Flynn, HW; Grzybowski, A; Relhan, N; Schwartz, SG	1
Brothers, KM; Dhaliwal, DK; Grewal, AS; Hunt, KM; Shanks, RMQ; Zhou, S	1
Kim, JY; Lee, SJ; Nam, KY	1
Anuradha, A; Nishath, S; Rashmi, G; Shilpa, R; Vidyadevi, M	1
Pujari, A; Singh, R; Temkar, S; Urkude, J	1
Ambati, BK; Bardsley, T; Bondalapati, S; Bowen, RC; Evans, PR; Greene, T; Kliethermes, M; Lawyer, TW; Mamalis, CA; McFarland, M; Rudnisky, CJ; Shi, D; Snow, KB; Zhou, AX	1
Ferreira, KSA; Gaete, MIL; Lira, RPC; Lucena, NP; Mélega, MV; Pereira, IMS	1
Dhaliwal, DK; Kowalski, RP; Mammen, A; Romanowski, EG; Shanks, RMQ	1
Gibbons, A; Koch, DD; Leung, EH; Stout, JT	1
Bond, WI; Brown, JA; Hahn, JM; Kishore, K; Satar, JM	1
Saramago, B; Serro, AP; Topete, A	1
He, YG; Patel, SB; Reddy, NK	1
Alves, M; Assis Filho, HL; Cardoso da Silva, I; Cavalcanti Lira, RP; Dias Freire, LM; Ferreira, BG; Leite Arieta, CE; Martini, AAF; Melega, MV; Pedreira Chaves, FR; Reis, RD	1
Agrawal, AK; Anjum, MM; Deepika, D; Gade, S; Gupta, C; Patel, KK; Singh, S	1
Dhaliwal, DK; Jhanji, V; Kowalski, RP; Mammen, A; Romanowski, EG; Shanks, RMQ	1
Alves, M; Assis Filho, HLG; Cardoso da Silva, I; Cavalcanti Lira, RP; Dias Freire, LM; Ferreira, BG; Leite Arieta, CE; Martini, AAF; Melega, MV; Pedreira Chaves, FR; Reis, RD	1
Lam, S	1
Rubinfeld, RS; Stulting, RD; Trattler, WB; Woolfson, JM	1
Chalam, KV; Ng, C	1
Chang, DF; Haripriya, A; Ravindran, RD	2
Daneman, N; Eng, KT; Kertes, PJ; Kohly, R; Lam, WC; Mandelcorn, E; Schwartz, C; Simor, A; Weisbrod, DJ; Yin, VT	1
Aktas, Z; Arikan, S; Dinçel, A; Hasanreisoglu, B; Ozdek, S	1
Bartz-Schmidt, KU; Hofmann, J; Sobolewska, B; Spitzer, MS; Szurman, P; Yoeruek, E	1
Akura, J; Inoue, Y; Matsuura, K; Miyoshi, T; Suto, C	1
Rudnisky, CJ; Wan, D; Weis, E	1
Kawasaki, S; Mitani, A; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T	1
Aggarwal, H; Ahmed, S; Edwards, P; Gao, H; Kuruvilla, O; Li, Y; Qiao, X; Yee, DC	1
Braga-Mele, R; Chang, DF; Henderson, BA; Mamalis, N; Talley-Rostov, A; Vasavada, A	1
Bairy, KL; Kamath, MG; Kamath, MM; Musmade, PB; Nayak, RR; Sharma, T	1
Cherof, AM; Kahook, MY; Seibold, LK; SooHoo, JR	1
Ben Eliahu, S; Kleinmann, G; Yovel, OS	1
Chang, DF; Haripriya, A; Namburar, S; Ravindran, RD; Smita, A	1
Ambati, BK; Messenger, WB; Sargent, S; Zhou, AX	1
Banta, JT; Flynn, HW; Schimel, AM; Stringham, JD	1
Bailey, R; Haller, JA; Hark, LA; Roman, JS; Tyson, SL; Zhan, T	1
Hof, H	1
Gupta, PC; Ram, J	1
Arbisser, LB	1
Fiscella, RG; Jensen, MK; Mooney, B; Moshirfar, M	1
Belani, S; Lane, SS; Masket, S; Osher, RH	1
Scoper, SV	1
Cavet, ME; Ward, KW; Zhang, JZ	1
Holland, EJ; Lane, SS; Lindstrom, RL	1
McCulley, JP	1
Callegan, MC; Moyer, AL; Novosad, BD; Ramadan, RT; Wiskur, B	1
Betanzos-Cabrera, G; Cancino-Díaz, JC; Cancino-Díaz, ME; González-González, G; Juárez-Verdayes, MA	1
de Kaspar, H; Eibl, KH; Hirneiss, C; Kampik, A; Kernt, M; Liegl, RG; Neubauer, AS; Ulbig, MW; Wolf, A	1
Akyürek, N; Deren, YT; Hasanreisoğlu, B; Kalkanci, A; Ozdek, S	1
Adebambo, B; Senthilvel, E; Shah, C	1
Hesje, CK; Marquart, ME; Moore, Q; Norcross, EW; Sanders, ME; Sanfilippo, CM; Shafiee, A	1
Akova, YA; Babaoğlu, MÖ; Bozkurt, A; Çetinkaya, A; Çolak, M; Güngör, SG; Yasar, Ü	1
Desai, RU; Enriquez, B; Schrier, A; Shaw, J; Smith, EF	1
Valle, DD; Villalobos, PA	1
Kim, JY; Kim, SY	1
Morris, TW; Scassellati Sforzolini, B; Sheets, JW	1
Bellini, LP; Bulla, MC; Martins, GM	1
Celen, MK; Ozekinci, S; Sakalar, YB	1
Alabiad, CR; Davis, JL; Miller, D; Schiffman, JC	1
Aslan, BS; Ekinci Koktekir, B	1
Hooper, CY; Khan, A; Lightman, SL; Pacheco, P; Tam, PM; Taylor, SR	1
de Oliveira, LA; de Sousa, LB; do Nascimento, HM; Ecker, DJ; Magalhães, FP; Rosenblatt, MI; Sampath, R; Sannes-Lowery, KA	1
Akura, J; Inoue, Y; Matsuura, K; Suto, C	1
Herrinton, LJ; Shorstein, NH; Winthrop, KL	1
Kawasaki, S; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T; Uno, T	1
Akova, YA; Asena, L; Bozkurt, A; Demiralay, E; Goktaş, MT; Karabay, G; Yaşar, U	1
Arvis, P; Bronner, S; Jehl, F; Monteil, H; Peter, JD; Ploy, MC; Prevost, G; Renault, C	1
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA	3
Cetinkaya, Z; Ermis, SS; Kiyici, H; Ozturk, F	1
Antoniadou, A; Chryssouli, Z; Giamarellou, H; Kampougeris, G; Kavouklis, E	1
Dahlin, DC; Faulkner, RD; Katz, HR; Lane, SS; Masket, S; McCue, BA; Orr, SC; Sall, K	1
Garweg, JG; Kodjikian, L	1
Bayar, B; Bozkurt, A; Dinçel, A; Duman, S; Kaya, E; Oflu, Y; Yağci, R; Yağci, S	1
Deramo, VA; Fastenberg, DM; Lai, JC; Udell, IJ	1
Basavanthappa, S; Feiz, V; Moshirfar, M; Vitale, AT; Wegelin, JA; Wolsey, DH	1
Bolinao, JG; Caparas, VL; Espiritu, CR	1
Bower, KS; Colyer, MH; Dick, JS; Haller, JA; Ward, TP; Weber, ED; Weichel, ED	1
Flynn, HW; Harper, T; Miller, D	1
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiyici, H; Ozturk, F	1
Antoniadou, A; Kampougeris, G	1
Arshinoff, SA; Mah, FS; O'Brien, TP	1
Bohigian, GM	1
Kampik, A; Kernt, M; Neubauer, AS; Ulbig, MW; Welge-Lüssen, U	1
Fuller, JJ; Hancock, HA; Lott, MN; Marcus, DM; McGwin, G; Singh, H; Singh, J	1
Karenchak, LM; Kowalski, RP; Mather, R; Romanowski, EG	1

Reviews

9 review(s) available for moxifloxacin and Infectious Endophthalmitis

Article	Year
Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes. Scientific reports, 2022, 10-18, Volume: 12, Issue:1 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; Moxifloxacin; Network Meta-Analysis; Postoperative Complications; Vancomycin	2022
Endophthalmitis after cataract surgery: an update on recent advances. Current opinion in ophthalmology, 2021, Volume: 32, Issue:1 Topics: Anti-Bacterial Agents; Cataract Extraction; Drug Implants; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Vancomycin; Vitrectomy; Vitreous Body	2021
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. The British journal of ophthalmology, 2018, Volume: 102, Issue:9 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections, Intraocular; Intraoperative Period; Moxifloxacin; Vancomycin	2018
Intracameral antibiotics: Safety, efficacy, and preparation. Journal of cataract and refractive surgery, 2014, Volume: 40, Issue:12 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pharmaceutical Preparations; Treatment Outcome; Vancomycin	2014
Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review. Current opinion in ophthalmology, 2017, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; Drug Compounding; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glucocorticoids; Humans; Intravitreal Injections; Moxifloxacin; Phacoemulsification; Postoperative Complications; Treatment Outcome; Triamcinolone Acetonide; Vancomycin	2017
Listeria infections of the eye. European journal of ophthalmology, 2017, Mar-10, Volume: 27, Issue:2 Topics: Animals; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Listeria monocytogenes; Listeriosis; Moxifloxacin	2017
Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis. Journal of cataract and refractive surgery, 2016, Volume: 42, Issue:12 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications	2016
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Advances in therapy, 2008, Volume: 25, Issue:10 Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Endophthalmitis; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmology; Quinolines	2008
Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:10 Topics: Anterior Chamber; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications; Quinolines	2007

Trials

10 trial(s) available for moxifloxacin and Infectious Endophthalmitis

Article	Year
Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification. Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:3 Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Endothelial Cell Loss; Double-Blind Method; Endophthalmitis; Endothelium, Corneal; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; No-Observed-Adverse-Effect Level; Phacoemulsification; Postoperative Complications; Prospective Studies; Visual Acuity	2020
Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India. Indian journal of ophthalmology, 2020, Volume: 68, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Young Adult	2020
Macular and choroidal thickness after intracameral moxifloxacin for prevention of postcataract endophthalmitis. Journal of cataract and refractive surgery, 2021, Jan-01, Volume: 47, Issue:1 Topics: Antibiotic Prophylaxis; Brazil; Endophthalmitis; Humans; Moxifloxacin; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Visual Acuity	2021
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Endothelial Cell Loss; Endophthalmitis; Female; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Prospective Studies; Visual Acuity	2019
Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan. Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:11 Topics: Anterior Chamber; Anti-Bacterial Agents; Aza Compounds; Cohort Studies; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Health Surveys; Humans; Injections, Intraocular; Japan; Lens Implantation, Intraocular; Moxifloxacin; Phacoemulsification; Quinolines; Retrospective Studies; Treatment Outcome	2013
Aqueous penetration of orally and topically administered moxifloxacin. The British journal of ophthalmology, 2015, Volume: 99, Issue:9 Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Chromatography, High Pressure Liquid; Endophthalmitis; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prospective Studies	2015
Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:9 Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cell Count; Endophthalmitis; Endothelium, Corneal; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Quinolines; Tomography, Optical Coherence; Visual Acuity	2008
Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. The British journal of ophthalmology, 2011, Volume: 95, Issue:9 Topics: Aged; Anti-Infective Agents; Aqueous Humor; Aza Compounds; Cataract; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Endophthalmitis; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Preoperative Care; Prospective Studies; Quinolines; Surgical Wound Infection; Treatment Outcome	2011
Penetration of moxifloxacin into the human aqueous humour after oral administration. The British journal of ophthalmology, 2005, Volume: 89, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Aza Compounds; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines	2005
Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea, 2005, Volume: 24, Issue:8 Topics: Absorption; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aqueous Humor; Aza Compounds; Cataract Extraction; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Endophthalmitis; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Preoperative Care; Quinolines	2005

Other Studies

112 other study(ies) available for moxifloxacin and Infectious Endophthalmitis

Article	Year
Clinical features and microbiology of post-cataract surgery endophthalmitis with and without intracameral moxifloxacin prophylaxis: Endophthalmitis prophylaxis study report 3. Indian journal of ophthalmology, 2022, Volume: 70, Issue:1 Topics: Adolescent; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Retrospective Studies	2022
ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2022,Summer, Volume: 78, Issue:4 Topics: Adult; Anti-Bacterial Agents; Colombia; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Imipenem; Male; Moxifloxacin; Referral and Consultation; Retrospective Studies; Vancomycin	2022
Relative efficacy of intracameral moxifloxacin injection methods. Journal of cataract and refractive surgery, 2023, 05-01, Volume: 49, Issue:5 Topics: Anterior Chamber; Anti-Bacterial Agents; Endophthalmitis; Fluoroquinolones; Humans; Injections; Moxifloxacin	2023
Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit. JPMA. The Journal of the Pakistan Medical Association, 2023, Volume: 73, Issue:1 Topics: Adult; Aged; Cataract; Cataract Extraction; Developing Countries; Endophthalmitis; Eye Diseases; Female; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Retrospective Studies; Triamcinolone	2023
Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2023, Volume: 261, Issue:10 Topics: Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Retrospective Studies; Vancomycin; Vitreous Body	2023
ASCRS clinical advisory on intracameral moxifloxacin injection for infection prophylaxis. Journal of cataract and refractive surgery, 2023, 10-01, Volume: 49, Issue:10 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications	2023
Reply: Relative efficacy of intracameral moxifloxacin injection methods. Journal of cataract and refractive surgery, 2023, 10-01, Volume: 49, Issue:10 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Fluoroquinolones; Humans; Moxifloxacin	2023
Prophylactic intracameral cefazolin and postoperative topical moxifloxacin after cataract surgery: endophthalmitis risk reduction and safety results in a 16-year study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2019, Volume: 257, Issue:10 Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Forecasting; Humans; Injections, Intraocular; Male; Moxifloxacin; Phacoemulsification; Postoperative Care; Retrospective Studies; Surgical Wound Infection	2019
Postoperative Endophthalmitis Before and After Preferred Utilization of Prophylactic Intracameral Antibiotics for Phacoemulsification Cataract Surgeries at Cole Eye Institute. Eye & contact lens, 2019, Volume: 45, Issue:5 Topics: Administration, Ophthalmic; Adult; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Female; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Postoperative Complications; Retrospective Studies; Visual Acuity	2019
Reducing the risk of endophthalmitis. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:9 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Risk Factors; Risk Reduction Behavior	2019
Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:11 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Bacteria; Cataract Extraction; Cefuroxime; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Vancomycin	2019
Moxifloxacin-loaded acrylic intraocular lenses: In vitro and in vivo performance. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:12 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Cells, Cultured; Disease Models, Animal; Drug Delivery Systems; Endophthalmitis; Lenses, Intraocular; Moxifloxacin; Rabbits	2019
Injection volume and intracameral moxifloxacin dose. Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:1 Topics: Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin	2020
Reply. Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:1 Topics: Endophthalmitis; Humans; Moxifloxacin	2020
Safety of intracameral moxifloxacin in the pediatric population: an equivalence study. Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:2 Topics: Adolescent; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Child; Child, Preschool; Conjunctiva; Corneal Edema; Corneal Pachymetry; Endophthalmitis; Endothelium, Corneal; Female; Follow-Up Studies; Humans; Infant; Injections, Intraocular; Intraocular Pressure; Lens Implantation, Intraocular; Male; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Visual Acuity	2020
Commentary: Role of antibiotics in cataract surgery. Indian journal of ophthalmology, 2020, Volume: 68, Issue:5 Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; India; Moxifloxacin	2020
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:2 Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole	2020
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report. Ocular immunology and inflammation, 2021, Nov-17, Volume: 29, Issue:7-8 Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Exfoliation Syndrome; Eye Pain; Gonioscopy; Humans; Male; Middle Aged; Moxifloxacin; Ocular Hypertension; Photophobia; Uveitis, Anterior	2021
Re-assessing Evidence for Adverse Ocular Reactions Associated with Fluoroquinolones: Implications for Intracameral Use. Ocular immunology and inflammation, 2022, 01-02, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Endophthalmitis; Eye; Fluoroquinolones; Humans; Moxifloxacin	2022
Klebsiella Cluster Endophthalmitis following Intravitreal Bevacizumab: Role of Early Detection, Pars Plana Vitrectomy, and Intracameral Moxifloxacin. Ocular immunology and inflammation, 2022, Jan-02, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Bevacizumab; Endophthalmitis; Humans; Intravitreal Injections; Klebsiella; Moxifloxacin; Retrospective Studies; Vitrectomy	2022
Reply: Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report. Ocular immunology and inflammation, 2022, 02-17, Volume: 30, Issue:2 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Fluoroquinolones; Humans; Moxifloxacin; Uveitis, Anterior	2022
Intravitreal moxifloxacin injections in acute post-cataract surgery endophthalmitis: Efficacy and safety. Indian journal of ophthalmology, 2021, Volume: 69, Issue:2 Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Moxifloxacin; Retrospective Studies; Vitrectomy	2021
Commentary: Intravitreal moxifloxacin for acute postoperative endophthalmitis: Is it as safe and efficacious as the age-old recommended intravitreal vancomycin and ceftazidime? Indian journal of ophthalmology, 2021, Volume: 69, Issue:2 Topics: Cataract; Ceftazidime; Endophthalmitis; Humans; Intravitreal Injections; Moxifloxacin; Vancomycin	2021
Incremental effect of topical and oral moxifloxacin administration with surgical intracameral prophylaxis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2021, Volume: 56, Issue:5 Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Quinolines	2021
Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery. American journal of ophthalmology, 2021, Volume: 227 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Retrospective Studies; Treatment Failure	2021
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes. Scientific reports, 2021, 03-18, Volume: 11, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy	2021
Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India. International ophthalmology, 2021, Volume: 41, Issue:8 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; India; Moxifloxacin; Postoperative Complications; Retrospective Studies	2021
Incidence of postoperative endophthalmitis with and without use of intracameral moxifloxacin. Indian journal of ophthalmology, 2021, Volume: 69, Issue:5 Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Incidence; Moxifloxacin; Postoperative Complications	2021
Reply: Advantages of intracameral injection with higher volume diluted moxifloxacin. Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:5 Topics: Endophthalmitis; Fluoroquinolones; Humans; Japan; Moxifloxacin	2017
Advantages of intracameral injection with higher volume diluted moxifloxacin. Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:5 Topics: Endophthalmitis; Fluoroquinolones; Humans; Moxifloxacin	2017
Relationship between moxifloxacin use and increased antibiotic resistance and possible anaphylactic reactions. Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:5 Topics: Anaphylaxis; Drug Resistance, Microbial; Endophthalmitis; Fluoroquinolones; Humans; Moxifloxacin	2017
Reply: Relationship between moxifloxacin use and increased antibiotic resistance and possible anaphylactic reactions. Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:5 Topics: Anaphylaxis; Drug Resistance, Microbial; Endophthalmitis; Fluoroquinolones; Humans; Moxifloxacin	2017
Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin. Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:6 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Moxifloxacin; Postoperative Complications; Vancomycin	2017
Standard preoperative topical antibiotics do not additionally benefit in postcataract endophthalmitis prophylaxis. Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:6 Topics: Anaphylaxis; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin	2017
Surface modification of an intraocular lens material by plasma-assisted grafting with 2-hydroxyethyl methacrylate (HEMA), for controlled release of moxifloxacin. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017, Volume: 120 Topics: Animals; Anti-Bacterial Agents; Cornea; Delayed-Action Preparations; Endophthalmitis; Endothelial Cells; Fluoroquinolones; Lab-On-A-Chip Devices; Lenses, Intraocular; Methacrylates; Moxifloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis	2017
Re: Haripriya et al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries (Ophthalmology. 2017;124:768-775). Ophthalmology, 2017, Volume: 124, Issue:9 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications	2017
Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification. Arquivos brasileiros de oftalmologia, 2017, Volume: 80, Issue:3 Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Endophthalmitis; Female; Fluoroquinolones; Humans; Injections, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Post-Exposure Prophylaxis; Postoperative Complications; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome	2017
Re: Haripriya et al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: an analysis of 600 000 surgeries (Ophthalmology. 2017;124:768-775). Ophthalmology, 2017, Volume: 124, Issue:10 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications	2017
Release of Moxifloxacin From Corneal Collagen Shields. Eye & contact lens, 2018, Volume: 44 Suppl 2 Topics: Anti-Bacterial Agents; Bandages; Collagen; Contact Lenses, Hydrophilic; Drug Delivery Systems; Endophthalmitis; Humans; Moxifloxacin; Ophthalmic Solutions	2018
Systemic Moxifloxacin in Streptococcus viridans Endophthalmitis. Ocular immunology and inflammation, 2019, Volume: 27, Issue:1 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Injections, Intraventricular; Moxifloxacin; Rabbits; Streptococcal Infections; Treatment Outcome; Viridans Streptococci; Vitreous Body	2019
Safety of Fixed drug Combination in Post -Operative Cataract Patients, at Tertiary Care Centre - In South India. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2017, Volume: 9, Issue:18 Topics: Anti-Bacterial Agents; Cataract Extraction; Dose-Response Relationship, Drug; Drug Combinations; Endophthalmitis; Female; Fluprednisolone; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intraocular Pressure; Male; Moxifloxacin; Ophthalmic Solutions; Postoperative Care; Postoperative Complications; Prospective Studies; Tertiary Care Centers	2017
Child with hypopyon. BMJ case reports, 2017, Oct-20, Volume: 2017 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Corneal Perforation; Diagnosis, Differential; Endophthalmitis; Eye Hemorrhage; Fluoroquinolones; Humans; Infant; Male; Moxifloxacin; Prednisolone; Ultrasonography; Vancomycin	2017
Intracameral moxifloxacin after cataract surgery: a prospective study. Arquivos brasileiros de oftalmologia, 2018, Volume: 81, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Female; Fluoroquinolones; Humans; Injections, Intraocular; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric; Time Factors; Treatment Outcome; Visual Acuity	2018
Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis. Eye & contact lens, 2018, Volume: 44 Suppl 2 Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Intravitreal Injections; Male; Moxifloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Triamcinolone	2018
Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery: Cost-effectiveness analysis. Journal of cataract and refractive surgery, 2018, Volume: 44, Issue:8 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cost-Benefit Analysis; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Moxifloxacin; Postoperative Complications	2018
Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin. Journal of cataract and refractive surgery, 2018, Volume: 44, Issue:12 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Phacoemulsification; Retrospective Studies; Surgical Wound Infection; Triamcinolone	2018
Dual drug delivery from intraocular lens material for prophylaxis of endophthalmitis in cataract surgery. International journal of pharmaceutics, 2019, Mar-10, Volume: 558 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Drug Delivery Systems; Drug Liberation; Endophthalmitis; Humans; Hydrogels; Ketorolac; Lenses, Intraocular; Models, Biological; Moxifloxacin; Staphylococcus aureus; Staphylococcus epidermidis	2019
TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN. Retina (Philadelphia, Pa.), 2020, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Posterior Eye Segment; Postoperative Complications; Retrospective Studies; Syndrome; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2020
An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea. Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:9 Topics: Administration, Ophthalmic; Alginates; Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Cornea; Drug Carriers; Drug Liberation; Drug Stability; Endophthalmitis; Gels; Goats; Humans; Hypromellose Derivatives; Lipids; Microbial Sensitivity Tests; Moxifloxacin; Nanoparticles; Permeability; Staphylococcus aureus; X-Ray Diffraction	2019
Endophthalmitis after intravitreal triamcinolone-moxifloxacin. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:5 Topics: Cataract; Endophthalmitis; Humans; Moxifloxacin; Triamcinolone Acetonide	2019
Reply. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:6 Topics: Cataract; Endophthalmitis; Humans; Moxifloxacin	2019
One-sided versus 2-sided statistical analysis of the safety and efficacy of intracameral moxifloxacin to prevent post-cataract endophthalmitis. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:6 Topics: Cataract; Endophthalmitis; Humans; Moxifloxacin	2019
Reply. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:6 Topics: Cataract; Endophthalmitis; Humans; Moxifloxacin	2019
Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery. European journal of ophthalmology, 2020, Volume: 30, Issue:5 Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Combinations; Drug Implants; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin, Dexamethasone Drug Combination; Triamcinolone; Vancomycin; Vitrectomy	2020
Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:9 Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Posterior Capsular Rupture, Ocular; Postoperative Complications; Registries; Retrospective Studies	2019
Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA ophthalmology, 2013, Volume: 131, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Aza Compounds; Bacteria; Ceftazidime; Cohort Studies; Conjunctiva; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Female; Fluoroquinolones; Hospitals, Teaching; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Moxifloxacin; Prospective Studies; Quinolines; Ranibizumab; Wet Macular Degeneration	2013
Vitreous and aqueous penetration of intravitreally and orally administered moxifloxacin in an experimental rabbit model of fungal endophthalmitis. The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:5 Topics: Animals; Antifungal Agents; Aqueous Humor; Aza Compounds; Candida albicans; Disease Models, Animal; Endophthalmitis; Eye Infections, Fungal; Fluoroquinolones; Moxifloxacin; Quinolines; Rabbits; Vitreous Body	2013
Antiproliferative and cytotoxic properties of moxifloxacin on rat retinal ganglion cells. Current eye research, 2013, Volume: 38, Issue:6 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endophthalmitis; Fluoroquinolones; Moxifloxacin; Quinolines; Rats; Retinal Ganglion Cells	2013
Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis. Ophthalmology, 2014, Volume: 121, Issue:4 Topics: Aged; Aged, 80 and over; Alberta; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Case-Control Studies; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Hospitals, Private; Hospitals, Public; Humans; Incidence; Male; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Vancomycin	2014
Ocular penetration and efficacy of levofloxacin using different drug-delivery techniques for the prevention of endophthalmitis in rabbit eyes with posterior capsule rupture. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2014, Volume: 30, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Moxifloxacin; Ophthalmic Solutions; Posterior Capsular Rupture, Ocular; Rabbits; Vitreous Body	2014
Intraocular penetration of systemic antibiotics in eyes with penetrating ocular injury. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2014, Volume: 30, Issue:10 Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Corneal Injuries; Endophthalmitis; Eye Injuries, Penetrating; Fluoroquinolones; Gram-Positive Bacterial Infections; Intravitreal Injections; Moxifloxacin; Rabbits; Sclera; Vancomycin; Vitreous Body	2014
Long-term effects of intracameral moxifloxacin. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:12 Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Endothelium, Corneal; Female; Fluoroquinolones; Follow-Up Studies; Fovea Centralis; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Moxifloxacin; Visual Acuity	2015
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation. Journal of glaucoma, 2016, Volume: 25, Issue:3 Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endophthalmitis; Fluoroquinolones; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Moxifloxacin; Prednisolone	2016
Prevention of Staphylococcus epidermidis Endophthalmitis by Different Moxifloxacin Prophylaxis Routes. Current drug delivery, 2016, Volume: 13, Issue:1 Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Fluoroquinolones; Lens, Crystalline; Moxifloxacin; Rabbits; Staphylococcus epidermidis	2016
Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital. Ophthalmology, 2016, Volume: 123, Issue:2 Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Charities; Drug Costs; Electronic Health Records; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Health Care Costs; Hospitals, Private; Hospitals, Public; Hospitals, Special; Humans; India; Male; Middle Aged; Moxifloxacin; Ophthalmology; Postoperative Complications; Registries; Retrospective Studies	2016
Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery. International ophthalmology, 2016, Volume: 36, Issue:4 Topics: Administration, Topical; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Female; Fluoroquinolones; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; No-Observed-Adverse-Effect Level; Ophthalmic Solutions; Phacoemulsification; Retrospective Studies; Visual Acuity	2016
Dropless Cataract Surgery: What Are the Potential Downsides? American journal of ophthalmology, 2016, Volume: 164 Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Lens Implantation, Intraocular; Moxifloxacin; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Risk Factors; Triamcinolone; Vancomycin	2016
Re: Haripriya et al.: Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital (Ophthalmology 2016;123:302-308). Ophthalmology, 2016, Volume: 123, Issue:12 Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications	2016
Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries. Ophthalmology, 2017, Volume: 124, Issue:6 Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Electronic Health Records; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; India; Lens Implantation, Intraocular; Male; Microsurgery; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Posterior Capsular Rupture, Ocular; Postoperative Complications; Registries; Retrospective Studies	2017
Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Injections; Lens Implantation, Intraocular; Macula Lutea; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome	2008
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Cross-Sectional Studies; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines; Retrospective Studies	2008
Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells. Current eye research, 2008, Volume: 33, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Aza Compounds; Azepines; Biological Transport; Cell Nucleus; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Endophthalmitis; Enzyme Activation; Epithelium, Corneal; Female; Fluoroquinolones; Humans; Interleukin-1beta; Mitogen-Activated Protein Kinases; Moxifloxacin; NF-kappa B; Quinolines; Rabbits	2008
Fluoroquinolones and postoperative endophthalmitis. Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:2 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines	2009
Fluoroquinolones and postoperative endophthalmitis. Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:2 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines	2009
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Advances in therapy, 2009, Volume: 26, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Benzalkonium Compounds; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Keratitis; Moxifloxacin; Ophthalmic Solutions; Postoperative Complications; Preservatives, Pharmaceutical; Quinolines; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Time Factors	2009
Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic research, 2009, Volume: 42, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; Conjunctivitis; Corneal Ulcer; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus epidermidis	2009
[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010, Volume: 107, Issue:8 Topics: Anterior Chamber; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endophthalmitis; Endothelial Cells; Epithelium, Corneal; Fluoroquinolones; Humans; In Vitro Techniques; Inflammation Mediators; Lens, Crystalline; Lipopolysaccharides; Moxifloxacin; Oxidative Stress; Pigment Epithelium of Eye; Quinolines; Trabecular Meshwork	2010
Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. Canadian journal of microbiology, 2010, Volume: 56, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Aza Compounds; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Infections, Fungal; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Vitreous Body	2010
Red eye, blurry vision, and cough. The Journal of family practice, 2010, Volume: 59, Issue:4 Topics: Anti-Infective Agents; Aortic Valve; Aortic Valve Insufficiency; Aza Compounds; Blindness; Ceftriaxone; Cough; Echocardiography, Transesophageal; Endophthalmitis; Fever; Fluoroquinolones; Hearing Loss, Sensorineural; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Moxifloxacin; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae; Vancomycin; Vision Disorders	2010
Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:3 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Fluoroquinolones; Gatifloxacin; Moxifloxacin; Ophthalmic Solutions; Penicillin Resistance; Pneumococcal Infections; Quinolines; Rabbits; Severity of Illness Index; Streptococcus pneumoniae; Time Factors	2010
Can intraocular lenses deliver antibiotics intracamerally? Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Chromatography, High Pressure Liquid; Drug Delivery Systems; Endophthalmitis; Fluoroquinolones; Hydrophobic and Hydrophilic Interactions; Lenses, Intraocular; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Time Factors	2010
[The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis]. Archivos de la Sociedad Espanola de Oftalmologia, 2010, Volume: 85, Issue:10 Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extraction; Cefuroxime; Clinical Trials as Topic; Endophthalmitis; Fluoroquinolones; Humans; Injections, Intraocular; Moxifloxacin; Ophthalmologic Surgical Procedures; Quinolines; Surgical Wound Infection	2010
Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis. Investigative ophthalmology & visual science, 2011, Mar-25, Volume: 52, Issue:3 Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intravenous; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin	2011
Relevance of aqueous humor concentrations of fluoroquinolones. Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:1 Topics: Anti-Infective Agents; Aqueous Humor; Aza Compounds; Azepines; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Endophthalmitis; Fluoroquinolones; Half-Life; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines	2011
Preventing endophthalmitis after cataract surgeries. The British journal of ophthalmology, 2011, Volume: 95, Issue:6 Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extraction; Endophthalmitis; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Quinolines	2011
Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:6 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacillus cereus; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye; Fluoroquinolones; Intravitreal Injections; Moxifloxacin; Quinolines; Rabbits; Time Factors; Treatment Outcome	2011
Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections. American journal of ophthalmology, 2011, Volume: 152, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Aza Compounds; Bacteria; Bacteriological Techniques; Conjunctiva; Drug Resistance, Bacterial; Endophthalmitis; Female; Fluoroquinolones; Humans; Intravitreal Injections; Macular Degeneration; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nasal Mucosa; Prospective Studies; Quinolines	2011
Safety of prophylactic intracameral moxifloxacin use in cataract surgery. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2012, Volume: 28, Issue:3 Topics: Aged; Aza Compounds; Cataract; Cataract Extraction; Cornea; Endophthalmitis; Female; Fluoroquinolones; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Post-Exposure Prophylaxis; Quinolines; Retina; Tomography, Optical Coherence; Visual Acuity	2012
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery. Acta ophthalmologica, 2012, Volume: 90, Issue:7 Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; Cataract Extraction; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body	2012
Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea, 2013, Volume: 32, Issue:4 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Aza Compounds; Corneal Diseases; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Molecular Diagnostic Techniques; Moxifloxacin; Povidone-Iodine; Prospective Studies; Prostheses and Implants; Quinolines; Staphylococcus aureus	2013
Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:1 Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Catheters; Chromatography, High Pressure Liquid; Endophthalmitis; Fluoroquinolones; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Moxifloxacin; Posterior Capsule of the Lens; Quinolines; Swine; Therapeutic Irrigation	2013
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:1 Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; California; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Incidence; Lens Implantation, Intraocular; Moxifloxacin; Phacoemulsification; Postoperative Complications; Quinolines; Vancomycin	2013
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:4 Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aphakia, Postcataract; Aza Compounds; Disease Models, Animal; Electroretinography; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Rabbits; Time Factors	2013
Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model. Current eye research, 2013, Volume: 38, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Endophthalmitis; Epithelium, Corneal; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intraocular; Microscopy, Electron, Transmission; Moxifloxacin; Phacoemulsification; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections; Vitreous Body	2013
Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Endophthalmitis; Exotoxins; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors	2003
Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. American journal of ophthalmology, 2004, Volume: 138, Issue:1 Topics: Administration, Topical; Animals; Anterior Chamber; Aza Compounds; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus	2004
Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model. The Tohoku journal of experimental medicine, 2005, Volume: 205, Issue:3 Topics: Adrenal Cortex Hormones; Animals; Anti-Infective Agents; Aza Compounds; Dexamethasone; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Inflammation; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Stem Cells; Time Factors; Vitreous Body	2005
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. American journal of ophthalmology, 2005, Volume: 140, Issue:3 Topics: Animals; Anterior Chamber; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections; Moxifloxacin; No-Observed-Adverse-Effect Level; Ophthalmic Solutions; Quinolines; Rabbits; Safety; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body	2005
Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model. American journal of ophthalmology, 2006, Volume: 141, Issue:4 Topics: Animals; Anterior Chamber; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections; Moxifloxacin; No-Observed-Adverse-Effect Level; Quinolines; Rabbits; Staphylococcal Infections	2006
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Eye (London, England), 2007, Volume: 21, Issue:7 Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body	2007
Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. American journal of ophthalmology, 2006, Volume: 142, Issue:5 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Cataract Extraction; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies	2006
Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology, 2007, Volume: 114, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Quinolines; Retrospective Studies; Vitreous Body	2007
Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:1 Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cell Count; Endophthalmitis; Endothelium, Corneal; Eye Infections; Female; Fluoroquinolones; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Visual Acuity	2007
Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom. Ophthalmology, 2007, Volume: 114, Issue:8 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Combined Modality Therapy; Endophthalmitis; Eye Enucleation; Eye Foreign Bodies; Eye Injuries, Penetrating; Female; Fluoroquinolones; Follow-Up Studies; Humans; Iraq; Levofloxacin; Male; Middle Aged; Military Medicine; Military Personnel; Moxifloxacin; Ofloxacin; Postoperative Complications; Prognosis; Quinolines; Retrospective Studies; Risk Factors; Time Factors; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Warfare	2007
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology, 2007, Volume: 114, Issue:5 Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin	2007
Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. Current eye research, 2007, Volume: 32, Issue:4 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Aza Compounds; Colony Count, Microbial; Dexamethasone; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edema; Endophthalmitis; Fluoroquinolones; Hyperemia; Injections; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body	2007
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye (London, England), 2007, Volume: 21, Issue:9 Topics: Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Endophthalmitis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcus epidermidis; Vitreous Body	2007
Endophthalmitis. Ophthalmology, 2008, Volume: 115, Issue:2 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Quinolines; Vitreous Body	2008
In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:3 Topics: Anti-Infective Agents; Astrocytes; Aza Compounds; Cell Proliferation; Cell Survival; Cells, Cultured; Endophthalmitis; Fluoroquinolones; Humans; Interleukin-6; Lipopolysaccharides; Moxifloxacin; Optic Disk; Oxidative Stress; Pigment Epithelium of Eye; Quinolines; Tumor Necrosis Factor-alpha	2008
Vitreal penetration of oral moxifloxacin in humans. Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Endophthalmitis; Fluoroquinolones; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Vitrectomy; Vitreous Body	2008
Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1 Topics: Administration, Topical; Animals; Anti-Infective Agents; Aza Compounds; Conjunctivitis; Endophthalmitis; Fluoroquinolones; Injections; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body	2008
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. American journal of ophthalmology, 2002, Volume: 133, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies	2002